Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ
about
Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responsesInflammation as a Keystone of Bone Marrow Stroma Alterations in Primary MyelofibrosisOncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathwaysEmerging translational approaches to target STAT3 signalling and its impact on vascular diseaseSTAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models.Roles of STATs signaling in cardiovascular diseases.IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma.The enigmatic cytokine oncostatin m and roles in diseaseTherapeutic neovascularization for coronary disease: current state and future prospects.Oncostatin m modulation of lipid storage.Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis.Oncostatin M Promotes Osteoblastic Differentiation of Human Vascular Smooth Muscle Cells Through JAK3-STAT3 Pathway.Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureThe role of oncostatin M regulates osteoblastic differentiation of dental pulp stem cells through STAT3 pathway.Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression.A comparison of left and right atrial fibroblasts reveals different collagen production activity and stress-induced mitogen-activated protein kinase signalling in rats.Lack of T-bet reduces monocytic interleukin-12 formation and accelerates thrombus resolution in deep vein thrombosis.Evaluation of carotid plaque neovascularization in patients with diabetes mellitus by contrast-enhanced ultrasonography.Interleukin-27, a novel cytokine induced by ischemia-reperfusion injury in rat hearts, mediates cardioprotective effects via the gp130/STAT3 pathway.
P2860
Q23918832-57C52F9F-C28D-4D43-A58F-045E042AEC35Q26774212-7E1B2BF9-48F6-407C-A958-ED4816E5C31CQ33613358-56A579AF-A9B0-4DED-8761-95D556C42860Q34196423-3A9B5CC1-28BC-47C6-9E9E-CE8E39D6A7E0Q35238090-3B89D8E7-8A2D-43E7-809C-BA90EB2FD7C7Q35580177-35A33407-6BC7-423F-8675-E6FD7E2FFD8BQ35925825-8E66BD06-DD7F-4AE3-ACAE-711D42371A6CQ36180362-DF233C6D-5A88-4872-ACC3-BE6F396FD322Q36895471-1E6678BF-C05A-4FF6-B3AB-F9B90015E015Q37397237-713041B4-6F0B-4444-9D11-1613442256B5Q37409222-9C4AB308-8759-46C3-8428-740090D77D16Q37895528-30972CDE-7093-4135-A8E3-24EE15124BD7Q38358416-2D3745B9-4D22-4D0B-B99A-BF7E9C47E53EQ39024059-7E7D15BF-247E-45C8-9C86-453C43AB0626Q41308566-F2DAB45B-6482-418F-A46B-92A9FFEAF23EQ41926961-FA069BE4-72AB-460D-895A-6A1F26883186Q42156210-75A09DEA-9435-464B-8A28-EF0DB1A433C7Q45402522-38D46E8E-A1B6-48F6-AEA4-57D6172658F4Q48719325-2400DED1-54AE-4748-B90C-EC268A5301CAQ51310867-9869D749-B728-497B-85CB-CD3AA729EE6DQ51751182-7DA92A36-B1BF-4E36-8CB1-B1F73DAD1F32Q53080695-B5A33F18-9E38-427A-A33A-C14633A21E98Q54168695-C4310D62-5C9D-489F-BF47-D40E9E812784
P2860
Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ
description
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 21 December 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2010
@uk
name
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@en
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@nl
type
label
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@en
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@nl
prefLabel
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@en
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@nl
P2093
P2860
P50
P1476
Oncostatin M-enhanced vascular ...... is attenuated by interferon-γ
@en
P2093
Gersina Rega
Katharina M Katsaros
Kathrin Rychli
Kurt Huber
Philipp J Hohensinner
Stefan P Kastl
Stefan Pfaffenberger
Svitlana Demyanets
Taras Afonyushkin
P2860
P2888
P304
P356
10.1007/S00395-010-0141-0
P577
2010-12-21T00:00:00Z